Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

NCT00084136 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1571

Enrollment

NETWORK

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Atazanavir
DRUG: Didanosine (enteric-coated)
DRUG: Efavirenz
DRUG: Emtricitabine
DRUG: Emtricitabine/Tenofovir disoproxil fumarate
DRUG: Lamivudine/Zidovudine

Sponsor

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Collaborators

[object Object]